Bioventus (BVS) Tax Provisions (2020 - 2026)
Bioventus' (BVS) quarterly Tax Provisions came in at $571000.0 in Q1 2026, up 701.05% YoY from $71281.2 in Q1 2025, and up 117.98% on a QoQ basis from -$3.2 million in Q4 2025.
Bioventus (BVS) Tax Provisions (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Tax Provisions data on file, last reported at $571000.0 in Q1 2026.
- Quarterly Tax Provisions rose 701.05% year-over-year to $571000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$899000.0 (up 85.72% YoY) and the FY2025 annual result came in at -$1.6 million, up 70.43% from the prior year.
- Tax Provisions climbed to $571000.0 in Q1 2026, from -$3.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.2 million in Q3 2022 to a low of -$29.5 million in Q4 2022.
- A 5-year average of -$3.0 million and a median of $381000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions plunged 6930.14% — and 2024, when it soared 721.23%.
- Tracing BVS's Tax Provisions over 5 years: stood at -$11.0 million in 2022, then soared by 93.16% to -$750000.0 in 2023, then surged by 173.33% to $550000.0 in 2024, then sank by 677.27% to -$3.2 million in 2025, then surged by 117.98% to $571000.0 in 2026.
- The last three Tax Provisions figures came in at $571000.0 (Q1 2026), -$3.2 million (Q4 2025), and $664000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 288.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 155.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 68.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 119.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -185.98 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 72.50 Mn |
| 10 | Bioventus | 976.64 Mn | 947.18 Mn | 105.67 Mn | -20.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -20.90 Mn |
| Mar 28, 2026 | 571,000.00 |
| Dec 31, 2025 | -3.18 Mn |
| Sep 27, 2025 | 664,000.00 |
| Jun 28, 2025 | 1.04 Mn |
| Mar 29, 2025 | -95,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 28, 2024 | 589,000.00 |
| Jun 29, 2024 | -7.34 Mn |
| Mar 30, 2024 | 907,000.00 |
| Dec 31, 2023 | -750,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jul 1, 2023 | 381,000.00 |
| Apr 1, 2023 | -146,000.00 |
| Dec 31, 2022 | -10.96 Mn |
| Oct 1, 2022 | -29.52 Mn |
| Jul 2, 2022 | 1.24 Mn |
| Apr 2, 2022 | -5.13 Mn |
| Dec 31, 2021 | -2.73 Mn |
| Oct 2, 2021 | -882,000.00 |